Ligand validation:1ZP3

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
1ZP3_MPD_C_497	34%	58%	0.188	0.873	1.23	0.39	1	-	1	0	100%	0.8
1ZP3_MPD_A_495	20%	55%	0.232	0.831	1.32	0.41	1	-	0	0	100%	0.65
1ZP3_MPD_B_496	12%	57%	0.279	0.811	1.27	0.4	1	-	1	0	100%	0.7
2FMO_MPD_A_895	49%	58%	0.192	0.941	1.26	0.35	1	-	1	0	100%	0.9
4QSR_MPD_A_1204	96%	63%	0.078	0.99	0.55	0.84	-	-	0	0	100%	1
3BUI_MPD_A_1048	95%	60%	0.069	0.974	0.57	0.95	-	-	0	1	100%	1
4WPG_MPD_A_301	95%	48%	0.056	0.958	0.43	1.57	-	3	1	0	100%	1
6JOW_MPD_B_901	93%	70%	0.066	0.962	0.34	0.77	-	-	3	0	100%	1
8PO9_MPD_D_910	93%	86%	0.081	0.976	0.3	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.